NSETrading Window28 Sept 2026 · 28 Sept 2026, 08:44 pm

Trading Window

Anlon Healthcare Limited · AHCL

✦ AI Summary

Anlon Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern5/10
Regulatory Risk5/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Anlon Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

ANLON2013_28092026204426_AHLClosureofTradingWindowSigned.pdf

pdf

Download →
View document text
September 28, 2026 To, To, Listing Department, The National Stock Exchange of India BSE Limited Ltd. Phiroze Jeejeebhoy Towers, The Listing Department Dalal Street, Exchange Plaza, Mumbai – 400 001 Bandra – Kurla Complex, Ref: BSE Scrip Code: 544497 Mumbai – 400051, NSE Scrip Code: AHCL Sub: Notice of Closure of Trading Window for Dealing in Securities of the Company Respected Sir/Madam, As per Captioned subject and as per the SEBI [Prohibition of Insider Trading] Regulations, 2015 and amendments thereto and as per policy on code of conduct for prevention of insider trading and fair disclosure of unpublished price sensitive information of the Company, we would like to inform you that the trading window for dealing in the securities of the Company shall be closed for Company's Promoters & Promoter group, Directors, Key Managerial Personnel, Designated Employees, Connected/Designated Persons and their immediate relatives of respective persons aforementioned with effect from Thursday, October 01, 2026 till the expiry of 48 hours after declaration of Unaudited Financial Results for the Quarter and Half Year ended September 30, 2026. This information is being informed to Company's Promoters & Promoter group, Directors, Key Managerial Personnel, Designated Employees, Connected/Designated Persons and Immediate relatives of respective persons in accordance with code of conduct. Accordingly, all aforesaid persons are advised not to trade in the securities of the Company during the aforesaid period of closure of trading window. We request you to kindly take the above on your record. Thanking You. For ANLON HEALTHCARE LIMITED PUNITKUMAR RASADIA MANAGING DIRECTOR DIN: 06696258 ANLON HEALTHCARE LIMITED CIN No.: L24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot-360005, Gujarat (INDIA) PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in